ARCHIVES

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

This article is from The Cancer Letter archive.

Vol. 18 No. 27 | July 3, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Congressman Carter To Address ACCC Annual Conference

December 3, 1976

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013

Obituaries: Keith Amos, Trudy Small, and Kie Kian Ang

June 21, 2013

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

Cancer Advocacy: March On Washington Scheduled For September 1998

October 31, 1997